(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BREVAGENPLUS

This trademark appears in the official USPTO history.

Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.

DEATH OF INTERNATIONAL REGISTRATIONType: CombinedOffice: United States

Quick snapshot

BREVAGENPLUS

ST13

US500000079187538

Class

1, 5, 42, 44

Filing

79187538

Registration

5052075

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

DEATH OF INTERNATIONAL REGISTRATION

Case type

Application and registration

Recorded events

18

Latest update

08/06/2026

Trademark type

Combined

Nice classes

1, 5, 42, 44

Filing date

01/15/2016

Registration date

10/04/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/15/2026

Last transaction

08/06/2026

Responsible office

United States Patent and Trademark Office

Status code

404

Official register

Principal Register

Drawing code

5

Owner type

99

Owner location

AU

Examiner

SWIFT, GILBERT M

Law office

L90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Genetic Technologies Limited

Representatives

FB Rice

Technical classification

Nice Classes

Class 1Class 5Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Diagnostic preparations and reagents for scientific use; diagnostic preparations and reagents for scientific laboratory use; diagnostic preparations comprised primarily of reagents and assays for scientific use

Class 5

Diagnostic preparations and reagents for clinical and medical use; diagnostic test preparations comprised primarily of reagents and assays for clinical and medical use

Class 42

Biotechnology research and development services for othersincluding genetic association studiesgenome mappinggenome analysis and genome scanningpharmaceutical drug and therapeutics development; product developmentincluding consumer health product development and consultation in the field of genomics and pharmaceutical drug development

Class 44

Medical diagnostic servicesincluding reagent sample testing and diagnostic services for others in the fields of science and medical research; genetic testing for medical purposesincluding genome mappinggenome analysisgenome scanning

Publications

History of USPTO decisions and trademark events.

18 publications found

DETH

DEATH OF INTERNATIONAL REGISTRATION

08/06/2026

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

01/29/2024

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

01/07/2024

INPC

INVALIDATION PROCESSED

01/07/2024

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

12/21/2023

C71T

CANCELLED SECTION 71

04/21/2023

GPNX

NOTIFICATION PROCESSED BY IB

01/26/2017

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/11/2017

FIMP

FINAL DISPOSITION PROCESSED

01/11/2017

GPAR

GRANT OF PROTECTION CREATED, TO BE SENT TO IB

11/03/2016

R.PR

REGISTERED-PRINCIPAL REGISTER

10/04/2016

PUBO

PUBLISHED FOR OPPOSITION

07/19/2016

NPUB

NOTICE OF PUBLICATION

06/29/2016

MAFR

APPLICATION FILING RECEIPT MAILED

06/14/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/13/2016

DOCK

ASSIGNED TO EXAMINER

06/10/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/10/2016

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

06/09/2016

Continuous trademark protection

Get notified about every new filing that threatens BREVAGENPLUS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.